, Volume 30, Issue 9, pp 681–690 | Cite as

Evaluation of an intensified insulin treatment and teaching programme as routine management of Type 1 (insulin-dependent) diabetes

The Bucharest-Düsseldorf Study
  • I. Mühlhauser
  • I. Bruckner
  • M. Berger
  • D. Cheţa
  • V. Jörgens
  • C. Ionescu-Tîrgovişte
  • V. Scholz
  • I. Mincu


It has been questioned whether aiming at near-normoglycaemia by intensified insulin treatment regimens is feasible and safe for the majority of patients with insulin-dependent diabetes. In this study, intensified insulin injection therapy (including blood glucose self-monitoring and multiple insulin injections) based upon a 5-day inpatient group teaching programme was evaluated in Type 1 (insulin-dependent) diabetes mellitus in the centralised health care system of Bucharest. One hundred patients (group A, initial HbA1 12.5%) were followed for 1 year on their standard therapy (individual teaching, no metabolic self-monitoring), and thereafter for 1 year on intensified therapy. Another 100 patients (group B, HbA1 12.3%) were followed for 2 years on intensified therapy. A third 100 patients (group C, HbA1 11.7%) were assigned to a basic 4-day inpatient group teaching programme with conventional insulin therapy (including self-monitoring of glucosuria and acetonuria) and followed for 1 year. Mean HbA1 remained unchanged after standard treatment (group A: 12.8% at 12 months), but decreased during intensified therapy (group A: 10.1% at 24 months; group B: 9.3% at 12 months, 9.5% at 24 months; p<0.0001). In group C, no change was found compared to standard treatment (i.e. group A at 12 months). Incidence rates of ketoacidosis were 0.16 episodes per patient per year during standard treatment, 0.01 during intensified treatment (p<0.01) and 0.04 in group C (p<0.025). Hospitalisation rates were reduced by 60% during intensified therapy and by 40% in group C. Frequency of severe hypoglycaemia was not significantly different between the three treatment regimens. Thus, under the condition that insulin treatment is based upon a structured and comprehensive training of the patient, intensified insulin injection therapy performed as routine treatment of Type 1 diabetes significantly lowers HbA1 levels without increasing the risk of severe hypoglycaemia.

Key words

Type 1 diabetes insulin therapy severe hypoglycaemia ketoacidosis patient education 


  1. 1.
    Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596Google Scholar
  2. 2.
    Jovanovic L, Peterson CM, Saxena BB, Dawood MY, Saudek CD (1980) Feasibility of maintaining normal glucose profiles in insulin-dependent pregnant diabetic women. Am J Med 68: 105–112Google Scholar
  3. 3.
    Schiffrin A, Belmonte MM (1982) Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. A one-year prospective study. Diabetes 31: 255–264Google Scholar
  4. 4.
    Reeves ML, Seigier DE, Ryan EA, Skyler JS (1982) Glycemie control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. Am J Med 72: 673–680Google Scholar
  5. 5.
    Unger RH (1982) Meticulous control of diabetes: benefits, risks, and precautions. Diabetes 31: 479–483Google Scholar
  6. 6.
    The DCCT Research Group (1986) The diabetes control and complications trial (DCCT). Design and methodologic considerations for the feasibility phase. Diabetes 35: 530–545Google Scholar
  7. 7.
    Mühlhauser I, Jörgens V, Berger M, Graninger W, Gürtler W, Hornke L, Kunz A, Schernthaner G, Scholz V, Voss HE (1983) Bicentric evaluation of a teaching and treatment programme for Type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 25: 470–476Google Scholar
  8. 8.
    Mühlhauser I, Berger M, Sonnenberg GE, Koch J, Jörgens V, Schernthaner G, Scholz V (1985) Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care 8: 268–273Google Scholar
  9. 9.
    Assal JP, Mühlhauser I, Pernet A, Gfeller R, Jörgens V, Berger M (1985) Patient education as the basis for diabetes care in clinical practice and research. Diabetologia 28: 602–613Google Scholar
  10. 10.
    Kramer MS, Shapiro SH (1984) Scientific challenges in the application of randomized trials. JAMA 252: 2739–2745Google Scholar
  11. 11.
    Chantelau EA, Sonnenberg GE, Stanitzek-Schmidt I, Best F, Altenähr H, Berger M (1982) Diet liberalization and metabolic control in type-1 diabetic outpatients treated by continuous subcutaneous insulin infusion. Diabetes Care 5: 612–616Google Scholar
  12. 12.
    Chantelau EA, Frenzen A, Gösseringer G, Hansen I, Berger M (1987) Intensive insulin therapy justifies simplification of the diabetes diet: a prospective study in insulin-dependent diabetics. Am J Clin Nutr 45: 958–962Google Scholar
  13. 13.
    Chantelau EA, Gösseringer G, Sonnenberg GE, Berger M (1985) Moderate intake of sucrose does not impair metabolic control in pump-treated diabetic out-patients. Diabetologia 28: 204–207Google Scholar
  14. 14.
    Mühlhauser I, Koch J, Berger M (1985) Pharmacokinetics and bioavailability of injected glucagon: differences between intramuscular, subcutaneous and intravenous administration. Diabetes Care 8: 39–42Google Scholar
  15. 15.
    Seidel A (1987) Comparison of methods of urine glucose measurement. M. D. Thesis, University of Düsseldorf, FRGGoogle Scholar
  16. 16.
    Ionescu-Tîrgovişte C, Mincu I, Simionescu L, Cheţa D, Mirodon Z, Sântu E, Popa E, Bîrnea A (1984) Disappearance rate of insulin antibodies after discontinuing insulin treatment in 42 Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 27: 592–595Google Scholar
  17. 17.
    Siegel S (1976) Nichtparametrische statistische Methoden. Fachbuchhandlung für Psychologie, FrankfurtGoogle Scholar
  18. 18.
    Mecklenburg RS, Benson EA, Benson JW, Fredlund PN, Guinn T, Metz RJ, Nielsen RL, Sannar CA (1984) Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA 252: 3265–3269Google Scholar
  19. 19.
    Klein R, Klein BEK, Davis MD (1983) Is cigarette smoking associated with diabetic retinopathy? Am J Epidemiol 118: 228–238Google Scholar
  20. 20.
    Peacock I, Tattersall RB, Taylor A, Douglas CA, Reeves WG (1983) Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control. Lancet 1: 149–152Google Scholar
  21. 21.
    The Kroc Collaborative Study Group (1984) Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial. N Engl J Med 311: 365–372Google Scholar
  22. 22.
    Bending JJ, Pickup JC, Keen H (1985) Frequency of diabetic ketoacidosis and hypoglycemie coma during treatment with continuous subcutaneous insulin infusion. Am J Med 79: 685–691Google Scholar
  23. 23.
    Feldt-Rasmussen B, Mathiesen ER, Deckert T (1986) Effect of two years of strict metabolic control of progression on incipient nephropathy in insulin-dependent diabetes. Lancet 2: 1300–1304Google Scholar
  24. 24.
    Dahl-Jørgensen KD, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes Ø (1986) Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy: the Oslo study. Br Med J 293: 1195–1199Google Scholar
  25. 25.
    Hanssen KF, Dahl-Jørgensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hansen O, Deckert T (1986) Diabetic control and microvascular complications: the near-normoglycaemic experience. Diabetologia 29: 677–684Google Scholar
  26. 26.
    Worth R, Home PD, Johnston DG, Anderson J, Ashworth L, Burrin JM, Appleton D, Binder C, Alberti KGMM (1982) Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. Br Med J 285: 1233–1240Google Scholar
  27. 27.
    The DCCT Research Group (1987) Diabetes control and complications trial (DCCT): results of feasibility study. Diabetes Care 10: 1–19Google Scholar
  28. 28.
    Basdevant A, Costagliola D, Lanöe JL, Goldgewicht C, Triomphe A, Metz F, Denys H, Eschwege E, Fardeau M, Tchobroutsky G (1982) The risk of diabetic control: a comparison of hospital versus general practice supervision. Diabetologia 22: 309–314Google Scholar
  29. 29.
    Potter J, Clarke P, Gale EAM, Dave SH, Tattersall RB (1982) Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? Br Med J 285: 1180–1182Google Scholar
  30. 30.
    Miller LV, Goldstein J (1972) More efficient care of diabetic patients in a county-hospital setting. N Engl J Med 286: 1388–1391Google Scholar
  31. 31.
    Mühlhauser I, Klemm AB, Boor B, Scholz V, Berger M (1986) Krankenhausaufenthalts- und Arbeitsunfähigkeitszeiten bei Patienten mit Typ-I-Diabetes. Einfluß eines Diabetes-Behandlungsund Schulungsprogramms. Dtsch Med Wochenschr 111: 854–857Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • I. Mühlhauser
    • 2
    • 3
  • I. Bruckner
    • 1
  • M. Berger
    • 2
  • D. Cheţa
    • 1
  • V. Jörgens
    • 2
  • C. Ionescu-Tîrgovişte
    • 1
  • V. Scholz
    • 2
  • I. Mincu
    • 1
  1. 1.Departments of Nutrition and Metabolism of the University Hospitals of BucharestRumania
  2. 2.Departments of Nutrition and Metabolism of the University Hospitals of DüsseldorfGermany
  3. 3.Medizinische Klinik der Universität Düsseldorf Abteilung für Stoffwechsel und ErnährungDüsseldorfGermany

Personalised recommendations